Krishna Soujanya Gunturu, Associate Chief, Clinical Trials and Correlative Science Research Hartford Health Cancer Institute at Hartford HealthCare, shared a post on LinkedIn:
“The Hartford HealthCare Cancer Institute has officially launched its first-in-human Phase 1A clinical trial, marking a significant milestone in the advancement of innovative cancer therapies.
We extend our heartfelt congratulations to our incredible team for their dedication, innovation, and tireless efforts in launching Phase 1A clinical trials.
This milestone reflects our unwavering commitment to advancing cancer care and bringing hope to patients through pioneering research.”
More Posts Featuring Krishna Soujanya Gunturu.